Tweets
Predictors of DAPSA28 remission in #PsA starting 1st TNF-inhibitor (13 369 bio-naive pts from 13 Euro registries) showed 6 mo remission 25% and 12 retention 63%. Remission predictors: younger age, Dz duration, males (OR 1.85), CRP >10 (OR 1.52) https://t.co/cTefy6xeUB https://t.co/b2Ok6HJgE1
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 8 months ago
HRT for RA? Not Yet
Dr. Aurelie Najm discusses OP0268 presented at EULAR 2023 in Milan, Italy.
@AurelieRheumo
https://t.co/hoyZ2Ezn4G https://t.co/XWfE1RHwpi
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 8 months ago
Abatacept Safety Outcomes Across 7 European Registries
A multinational registry analysis of rheumatoid arthritis receiving abatacept has shown that the safety profile of ABA remains unchanged with no new or increased risks of infection or malignancy.
https://t.co/XcOSLTgQVR https://t.co/ZfwAA0baRM
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 8 months ago
2023 EULAR Recommendations on Imaging in Crystal-Induced Arthritis
These included 5 overarching principles & 10 recommendations on the role of imaging in making a diagnosis, monitoring, predicting, guiding therapy, and patient education in CiA.
https://t.co/5WoIm8OPZs https://t.co/xqNxDvuymJ
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 8 months ago
RheumNow’s newly launched Poster Hall features sponsor-generated clinical trial posters designed to educate and inform. Posters addressing vasculitis, AxSpa and nrAxSpa, and PMR now available.
https://t.co/0dV23VPDQH https://t.co/HfKhji40vU
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 8 months ago
Watch: Should you Assess Rheumatoid Factor Serially?
Dr. Jack Cush discusses abstract OP0272 at EULAR 2023 in Milan, Italy.
https://t.co/5e4SiPGDUM https://t.co/CzE597Auwg
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 8 months ago
Watch: De Novo Renal Nephritis Flares During Belimumab Trials
Drs. Yuz Yusof and Iaonnis Parodis discuss abstract POS1156 at EULAR 2023 in Milan, Italy.
https://t.co/XLzDF2VZ7Q https://t.co/iE16Ag3Rsu
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 8 months ago
How Often Do You Monitor MTX?
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow including new drug approval, a new SpA variant and new rules for methotrexate (MTX) monitoring and depression screening.
https://t.co/niPFjQTenh https://t.co/JyL8t6EexT
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 8 months ago
Pediatric Rheumatologist Loan assistance repayment program from HSRA. A loan assistance of up to $100,000 to eligible pediatric medical subspecialists in exchange for a 3-year, full-time service commitment at an approved facility in an underserved area https://t.co/6oFkEEKAY9
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 8 months ago
Chronic Pain Management tools
1 Medication
2 Physical Therapy
3 Cognitive-Behavioral Therapy
4 Mindfulness Meditation
5 Acupuncture
6 Massage
7 Heat/Cold
8 TENS
9 Yoga/Tai Chi
10 Support groups https://t.co/VBvYR8VK16 https://t.co/tbfPnL1VEH
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 8 months ago
Using Optum claims data from 2009 to 2021, they identified 524 IgG4-RD pts (mean age 56 yrs), incidence increased over time 0.78 to 1.39/100K Pt Yrs 2015 and 2019. Prevalence (1/19) was 5.3/100K Pt-Yrs, w/ mortality rate 3.42/100 Pt-Yrs (HR 2.51) https://t.co/22eIjtC7kp https://t.co/8RlEtZiX9j
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 8 months ago
Rheums! Have a rheumatology question or case for Jack Cush? Record it here and we may feature it on an upcoming podcast. Tell us your name and where you practice rheumatology.
https://t.co/3atPdJwb1m https://t.co/MKbgzEi9pd
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 8 months ago
